Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CSBRCSBR
17 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CHAMPIONS ONCOLOGY INC

Yes. Citadel Advisors holds 18,295 shares of CSBR (Champions Oncology), worth $112,697, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$112,697

Current Shares

18,295

Total Value Change

-$18,303

Total Shares Change

+2,216

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
18,295
-
$112,6970.0%$6.16
34
2025-Q4
Exited
0
-100.0%
$00.0%$6.91
0
2025-Q3
New
16,326
-
$105,7110.0%$6.48
33
2025-Q2
Exited
0
-100.0%
$00.0%$7.37
0
2025-Q1
Increased
22,902
+110.7%
$198,7890.0%$8.68
25
2024-Q4
New
10,868
-
$93,1390.0%$8.57
33
2024-Q3
Exited
0
-100.0%
$00.0%$4.87
0
2024-Q2
Decreased
10,218
-20.3%
$52,8270.0%$5.17
0
2024-Q1
Decreased
12,825
-12.3%
$62,8430.0%$4.90
0
2023-Q4
Increased
14,627
+33.8%
$79,1320.0%$5.62
19
2023-Q3
Decreased
10,932
-29.1%
$67,9970.0%$6.21
0
2023-Q2
Increased
15,415
+23.5%
$96,9600.0%$6.38
18
2023-Q1
Decreased
12,484
-67.2%
$50,1860.0%$4.02
0
2022-Q4
Increased
38,017
+1.9%
$171,4570.0%$4.51
16
2022-Q3
Increased
37,313
+124.8%
$280,0000.0%$7.50
38
2022-Q2
Increased
16,597
+3.2%
$134,0000.0%$8.00
16
2022-Q1
New
16,079
-
$131,0000.0%$8.13
34

Other major holders of CSBR: VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used